Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Biocardia Inc (BCDA)

Biocardia Inc (BCDA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Biocardia Inc 320 Soquel Way Sunnyvale CA 94085 USA

www.biocardia.com Employees: 20 P: 650-226-0120 F: 650-631-3731

Description:

BioCardia Inc. is engaged in developing regenerative biologic therapies to treat cardiovascular disease. The company's product candidate consists of CardiAMP(TM), CardiALLO(TM) and Helix Biotherapeutic Delivery System(TM) in clinical development stage. BioCardia Inc. is headquartered in San Carlos, California.

Key Statistics

Overview:

Market Capitalization, $K 9,031
Enterprise Value, $K 7,931
Shares Outstanding, K 4,584
Annual Sales, $ 480 K
Annual Net Income, $ -11,570 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -1,650 K
EBIT, $ -8,610 K
EBITDA, $ -8,530 K
60-Month Beta 1.25
% of Insider Shareholders 20.00%
% of Institutional Shareholders 20.57%
Float, K 3,667
% Float 80.00%
Short Volume Ratio 0.42

Growth:

1-Year Return -79.76%
3-Year Return -94.73%
5-Year Return -96.48%
5-Year Revenue Growth -23.81%
5-Year Earnings Growth -52.78%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.61 on 11/13/24
Next Earnings Date N/A
Earnings Per Share ttm -5.38
EPS Growth vs. Prev Qtr 30.68%
EPS Growth vs. Prev Year 66.09%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-15 on 05/30/24

BCDA Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % -208.38%
Profit Margin % -2,410.42%
Debt/Equity 0.00
Price/Sales 18.93
Price/Cash Flow N/A
Price/Book 3.02
Book Value/Share -1.08
Interest Coverage -1.63
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar